Alector IncALEC
Price$1.85

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 30 Jun 2026
Market Price $1.85Price as of 30 Sep 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 21.9%/yr (balance of the path).18.3% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 621.2%Yr 720.4%Yr 819.7%Yr 919.0%Yr 1018.3%
21.9% → 18.3%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1116.8%Yr 1215.2%Yr 1313.7%Yr 1412.2%Yr 1510.7%Yr 169.1%Yr 177.6%Yr 186.1%Yr 194.5%Yr 203.0%
18.3% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 8.2%
Volatility vs market (adjusted beta)0.73

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAlector IncALECHealth Care
Valuation
P/E—
P/S15.4×
P/B—
EV / Revenue11.8×
EV / EBITDA-0.2×
Profitability
Gross margin100.0%
Operating margin-2,500.0%
Net margin-850.1%
FCF margin-1,142.6%
Returns
ROE—
ROA-58.1%
ROIC—
Growth
Revenue growth (YoY)-86.2%
5-yr fwd EPS growth18.3%
Financial strength
Debt / Equity—
Current ratio5.26×
Altman Z-Score-7.5
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.